Cargando…
Dysfunctional Muscle and Liver Glycogen Metabolism in mdx Dystrophic Mice
BACKGROUND: Duchenne muscular dystrophy (DMD) is a severe, genetic muscle wasting disorder characterised by progressive muscle weakness. DMD is caused by mutations in the dystrophin (dmd) gene resulting in very low levels or a complete absence of the dystrophin protein, a key structural element of m...
Autores principales: | Stapleton, David I., Lau, Xianzhong, Flores, Marcelo, Trieu, Jennifer, Gehrig, Stefan M., Chee, Annabel, Naim, Timur, Lynch, Gordon S., Koopman, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953428/ https://www.ncbi.nlm.nih.gov/pubmed/24626262 http://dx.doi.org/10.1371/journal.pone.0091514 |
Ejemplares similares
-
Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice
por: Swiderski, Kristy, et al.
Publicado: (2014) -
Investigating the Potential for Sulforaphane to Attenuate Gastrointestinal Dysfunction in mdx Dystrophic Mice
por: Swiderski, Kristy, et al.
Publicado: (2021) -
Spatiotemporal Mapping Reveals Regional Gastrointestinal Dysfunction in mdx Dystrophic Mice Ameliorated by Oral L-arginine Supplementation
por: Swiderski, Kristy, et al.
Publicado: (2020) -
Muscle-specific deletion of SOCS3 increases the early inflammatory response but does not affect regeneration after myotoxic injury
por: Swiderski, Kristy, et al.
Publicado: (2016) -
Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice
por: Ham, Daniel J., et al.
Publicado: (2019)